INTRODUCTION
Diversity along the anterior-posterior axis of animals results from differential expression of Hox transcription factors, which regulate different sets of target genes to determine the features specific to each anatomical region (McGinnis and Krumlauf, 1992) . For example, in Drosophila, Sex combs reduced (Scr) determines anterior thoracic segments (Struhl, 1982; Wakimoto and Kaufman, 1981) , whereas Ultrabithorax (Ubx) and abdominalA (abdA) specify thoracic and abdominal segments (Lewis, 1978; Sá nchez-Herrero et al., 1985) .
Hox protein specificity is paradoxical, because all Hox proteins have similar DNA binding domains (the homeodomain), particularly for residues that contact DNA directly (Akam, 1989; McGinnis and Krumlauf, 1992) . As a result, all Hox proteins bind similar DNA sequences with high affinity (Berger et al., 2008; Mann et al., 2009; Noyes et al., 2008) . In principle, one solution to this paradox is that sequences outside of the homeodomain, which have diverged among Hox proteins, allow interactions with a diversity of cofactors to confer specificity. However, only two cofactors, the homeodomain proteins Extradenticle/Pbx (Exd) and Homothorax/MEIS (Hth) (Moens and Selleri, 2006) , are known to interact with Hox proteins (Chan et al., 1994; Chang et al., 1995; Mann et al., 2009 ). Exd dimerizes with Hox proteins and Hth facilitates nuclear localization and DNA binding of Exd (Pai et al., 1998; Rieckhof et al., 1997; . Thus, Hox specificity is unlikely to arise from interactions with a diversity of cofactors.
However, Hox protein structure is altered when bound to DNA with Exd, resulting in increased binding site specificity of HoxHth-Exd complexes in comparison with Hox monomers (Joshi et al., 2007; Slattery et al., 2011) . In vivo support for this latent specificity model came from studies of artificial enhancers containing multimerized Hox-Exd binding sites . Therefore, it is not clear whether this mechanism is sufficient to account for the high degree of regulatory specificity exhibited by Hox proteins on native enhancers.
One clue that may inform the Hox specificity paradox is that many enhancers, including Hox-regulated enhancers, contain multiple binding sites for the same transcription factor (Arnone and Davidson, 1997; Gotea et al., 2010; Lifanov et al., 2003; Ochoa-Espinosa et al., 2005; Papatsenko et al., 2002; Stanojevic et al., 1991) . These so-called homotypic binding site clusters are widespread, but the functions of clustered binding sites are understood in only a few cases. For example, homotypic clusters can fine-tune the response to graded transcription factors levels Gaudet and Mango, 2002; Jiang and Levine, 1993; Rowan et al., 2010; Struhl et al., 1989) , control the timing of enhancer activation (Gaudet and Mango, 2002) , or determine whether binding results in repression or activation (Ramos and Barolo, 2013) . However, elimination of individual binding sites in homotypic clusters often has little or no effect on enhancer activity (Doniger et al., 2005; Hersh and Carroll, 2005; Saramä ki et al., 2006; Stanojevic et al., 1991) , suggesting that there may be additional reasons for the widespread existence of homotypic binding site clusters.
To gain insight into the Hox specificity paradox, we asked how Hox factors regulate native enhancers to achieve a specific pattern of epidermal trichomes along the anterior-posterior axis of Drosophila larvae. Trichome patterns display strong differences between adjacent segments in a Hox-dependent manner (Lewis, 1978; Sá nchez-Herrero et al., 1985) . Because shavenbaby (svb) is the master control gene for trichome development (Chanut-Delalande et al., 2006; Delon et al., 2003; Payre et al., 1999) , we examined whether and how Hox factors regulate svb. We found that svb enhancers are directly regulated by Ubx and that they solve the Hox specificity paradox by employing clusters of low affinity Ubx-Exd binding sites. Specificity is encoded by low affinity sites and homotypic clusters of these sites provide regulatory robustness. This overall architecture-homotypic clusters of low affinity binding sites-is evolutionarily conserved and may provide a general mechanism to reconcile the need for both enhancer specificity and robustness.
RESULTS

Ubx Positively Regulates svb Expression
In wild-type embryos of Drosophila melanogaster, cells of the ventral first abdominal segment (A1) differentiate a row of stout trichomes ( Figure 1B ). These trichomes were lost in the absence of Ubx ( Figure 1D ). Reciprocally, ectopic expression of Ubx using a heat shock inducible promoter (HS:Ubx) caused production of ectopic trichomes in thoracic segments ( Figure 1F ) (Gonzá lez-Reyes and Morata, 1990; Mann and Hogness, 1990) . Because svb controls trichome development (ChanutDelalande et al., 2006) , we tested whether Ubx regulates svb expression. In wild-type embryos, svb was expressed strongly in cells of A1 and other abdominal segments that generate ventral trichomes and only weakly in the third thoracic segment ( Figure 1A ). In the absence of Ubx, svb expression was reduced in segment A1 ( Figure 1C) , consistent with the loss of the A1 trichomes in these larvae ( Figure 1D ). When we expressed Ubx ubiquitously, svb was upregulated in thoracic segments in a pattern similar to svb expression in segment A1 ( Figure 1E ). These results indicate that Ubx is required for expression of svb in the cells that generate A1 trichomes and that Ubx is sufficient to induce ectopic expression of svb when misexpressed in thoracic segments.
Ubx Controls Multiple svb Enhancers
To determine how Ubx regulates svb expression, we examined the effects of altered Ubx expression on two svb enhancers, called E and 7, that drive ventral stripes of expression ( Figure 1G ) (Frankel et al., 2010 (Frankel et al., , 2011 McGregor et al., 2007) . Through systematic functional dissection, we identified a 292 bp region of E, called E3N, and a 1,056 bp region of 7, called 7H ( Figure S1 available online ; Table S1 ), that each drove expression that accurately recapitulated the ventral patterns generated by the larger regions from which they were derived.
In wild-type embryos, E3N and 7H reporter genes were expressed in ventral rows of segments A1-A8 (Figures 1H and 1I) . In embryos that lacked Ubx, E3N and 7H reporter gene expression was lost in the A1 segment ( Figures 1J and 1K ) and reduced in A2-A8 segments ( Figures 1H-1K) , consistent with the reduction in trichome numbers caused by loss of Ubx function (Lewis, 1978) . Ectopic Ubx caused ectopic expression of E3N and 7H in thoracic segments and increased expression in abdominal segments ( Figures 1L and 1M) . In response to all manipulations of Ubx function, the expression patterns driven by E3N and 7H were similar to endogenous svb expression . Therefore, these two enhancers respond to Ubx and, at least in part, capture the regulatory inputs of Hox genes to establish the anterior-posterior pattern of svb expression and trichomes.
Hox proteins bind DNA with Exd and Hth ) and embryos lacking either hth or exd display homeotic transformations of trichome patterns (Jü rgens et al., 1984; Peifer and Wieschaus, 1990; Rieckhof et al., 1997 embryos suggests that multiple Hox genes activate these enhancers. While Ubx specifies the trichomes in A1, it acts together with abdA to specify trichomes in more posterior segments (Lewis, 1978) . Ubx and AbdA have similar DNA-binding specificities in complex with Exd (Karch et al., 1990; Slattery et al., 2011) and either Ubx or abdA is sufficient to drive svb expression in ventral abdominal stripes (Coiffier et al., 2008) . Accordingly, we found that embryos deficient for Ubx and abdA expressed neither E3N nor 7H in abdominal stripes (see below), indicating that both Ubx and AbdA activate the E3N and 7H svb enhancers.
Ubx Regulates the E3N and 7H Enhancers Directly through Multiple Low Affinity Binding Sites To determine whether Ubx binds to svb enhancers, first we examined genome-wide Ubx and Hth chromatin immunoprecipitation data (Choo et al., 2011) . These data revealed in vivo binding of Ubx and Hth at the E3N and 7H regions, as well as at other svb enhancer regions ( Figure S1 ). These results suggest that Ubx may regulate the E3N and 7H svb enhancers directly, which we tested further below. Surprisingly, the DNA sequences of E3N and 7H contained no Hox-Exd sites that match those previously identified by systematic evolution of ligands by exponential enrichment sequencing (SELEX-seq) (Slattery et al., 2011) . Therefore, we systematically searched for Ubx binding sites in E3N using electrophoretic mobility shift assays (EMSAs) of overlapping DNA fragments (Figures 2A and S2 ; Table S2 ). Ubx showed concentrationdependent binding to E3N1 and E3N2 fragments, but only when in complex with both Hth and Exd ( Figures 2C, S2B , and S2C). These fragments bound Ubx-Exd in complex with either full-length Hth (Hth FL ) or with Hth HM , similar to a naturally occurring isoform of Hth that lacks a homeodomain but that can translocate Exd to the nucleus Figure S3 ) and found that most of the Ubx-Exd binding activity came from three sites ( Figure 2C ). Mutation of each of two binding sites in E3N1 reduced Ubx-Exd binding and mutation of both together abolished Ubx-Exd binding (Figure 2C , see also Figure S3 ). In the E3N2 fragment, we found a third site that, when mutated, abolished Ubx-Exd binding ( Figures S3P and S3Q ). Mutation of an additional site located near the 5 0 end of E3N1 also reduced Ubx-Exd binding, suggesting that this region may contain another low affinity Ubx-Exd binding site ( Figures S2 and S3D ). The Ubx-Exd binding sites in E3N show variable levels of evolutionary conservation and only site 3 is conserved across all sequenced Drosophila species. We next tested, in vivo, the role of Ubx-Exd sites identified in vitro by generating transgenic constructs with all possible combinations of the three sites mutated (Figure 2 ). Mutation of either site 1 or site 3 reduced the expression levels driven by E3N ( Figures 2F, 2G , 2J, and 2K). Mutation of site 2 had no detectable effect on E3N expression (Figures 2H and 2I) , including when combined with either site 1 or site 3 mutations ( Figures 2L, 2M , 2P, and 2Q). However, when both site 1 and site 3 were mutated, the E3N enhancer still drove weak expression, which was reduced further upon knockout of site 2 ( Figures 2N, 2O , 2R, and 2S). Thus, all three Ubx-Exd sites in the E3N enhancer are functional in vivo.
We obtained very similar results for Ubx binding to the 7H enhancer. In vitro assays identified three low affinity Ubx-Exd binding sites in 7H (Figures S4A and S4B ). Individual mutation Tables S1 and S2. of each of the three Ubx-Exd binding sites did not modify the activity of 7H in embryos, either qualitatively ( Figures S4C, S4G , S4K, and S4O) or quantitatively ( Figures S4D, S4H , S4L, and S4P). In contrast, simultaneous mutation of sites 1 and 2, or sites 2 and 3, decreased 7H activity ( Figures S4E-S4N ) and mutation of all three sites almost completely abrogated 7H expression ( Figures S4Q and S4R ). Collectively, these results indicate that, as observed for E3N, the 7H svb enhancer uses at least three low affinity Ubx-Exd sites to drive expression along the AP axis of embryos. The absence of Ubx-Exd sites in E3N or 7H that match those detected by SELEX-seq (Slattery et al., 2011) implies that these sites have very low affinity for Ubx-Exd (see below). In addition to Ubx, the E3N and 7H enhancers are regulated in vivo by abdA ( Figure S5 ). Therefore, we tested whether the Ubx-Exd sites we identified could also bind AbdA-Hth-Exd (AbdA-Exd). In vitro, AbdA-Exd bound to the same E3N and 7H binding sites as Ubx-Exd did, and binding was abrogated when these sites were mutated ( Figure S5 ). Thus, Ubx-Exd and AbdA-Exd directly regulate the E3N and 7H enhancers through the same binding sites.
Taken together, these data show that both the E3N and 7H svb enhancers contain clusters of low affinity Ubx/AbdA-Exd binding sites that are required to drive svb expression in ventral abdominal stripes. They further indicate that these sites mediate the action of Ubx in segment A1 and Ubx plus AbdA in segments A2-A8.
Proper Regulation of a svb Enhancer Requires Low Affinity Ubx Binding Sites
While our in vivo assays demonstrated that all of the Hox-Exd sites in E3N and 7H are required for proper function, it is not clear why these enhancers employ low affinity rather than higher affinity binding sites. We hypothesized that the low affinity of these binding sites may be part of the solution to the Hox specificity paradox. To explore this idea, we analyzed previously published data in which the DNA sequence preferences of all Drosophila Hox-Exd complexes were measured using SELEX-seq, resulting in relative affinity scores from 0.03 to 1 (Slattery et al., 2011) . Using these data, we asked if there was any correlation between affinity and specificity. For example, do sequences with low affinity versus high affinity for Ubx-Exd display preference for Ubx-Exd compared to other Hox-Exd complexes? The results of this analysis were striking; only sequences with a relative affinity lower than 0.3 bound Ubx/AbdA-Exd specifically compared to the other Hox-Exd complexes (Figure 3) . Moreover, as the relative affinity for Ubx/AbdA-Exd decreased, the number of sequences that bound specifically to Ubx/AbdA-Exd increased (Figure 3 ). These data imply that Hox-Exd complexes display, at least in vitro, a tradeoff between binding affinity and specificity.
To test whether this affinity-specificity tradeoff holds in vivo, we generated E3N transgenic variants in which we varied the affinity of the Ubx-Exd binding sites according to the relative affinities predicted by SELEX-seq ( Figure 4A ) (Slattery et al., 2011) . Although none of the binding sites found in the native svb enhancer were identified by SELEX-seq, we estimate (based on the core 8-mer) that they have relative affinities <0.03 (Slattery et al., 2011) . Every mutation that increased the affinity of UbxExd sites resulted in qualitative or quantitative changes in E3N enhancer expression (Figure 4 ). For example, converting either native sites 1 or 2 to high-affinity sites (scores of 0.87 or 0.79, respectively) resulted in increased expression in the normal domain of E3N and ectopic expression anteriorly and dorsally ( Figures 4C and 4D ). Replacing site 3 in E3N with the highest affinity site (score of 1.0) also resulted in ectopic expression in anterior segments and in the intestine ( Figure 4B ). We further explored the functional consequences of gradually increasing the affinity of a Hox-Exd binding site by replacing site 3 with sites that have a range of relative affinities, from 0.06 to 0.72. A small increase in affinity to 0.06 resulted in higher levels of E3N expression within its normal expression domain ( Figures 4H  and 4I ). Increasing the affinity to 0.25, 0.65, and 0.72 altered levels of expression in the normal domains of E3N and induced ectopic expression in anterior segments (white arrows in Figures  4E-4G) .
We also observed strong position effects of a high affinity site, similar to observations in a previous study (Swanson et al., 2010) . Placing the highest affinity site 5 0 of the E3N enhancer resulted in ectopic expression in anterior segments, but decreased expression in the normal domain ( Figure S6B ). In contrast, placing this site inside the enhancer increased expression in the normal domain and generated ectopic expression in multiple regions ( Figure S6C ). We cannot rule out the possibility, however, that The proportion of 12mer sequences bound by various Hox-Exd complexes versus relative affinity of these 12mers for Ubx/AbdA-Exd is shown as colored bars (specificity groups). The number of 12mers in each affinity bin is plotted as a gray line. Average relative affinities of 12mers were calculated for four pairs of Hox-Exd complexes with similar binding profiles: (1) Labial and Pb, (2) Dfd and Scr, (3) AbdB and Antp, and (4) Ubx and AbdA. Sequences specific for Ubx/AbdA-Exd (green bars) are more prevalent in lower affinity bins than in higher affinity bins.
these position-dependent effects resulted from the creation or destruction of binding sites for additional factors. Taken together, these results indicate that Hox-Exd sites with higher affinity than the native sites alter the specificity of the svb enhancer, demonstrating that the affinity-specificity tradeoff that was inferred from in vitro data also pertains in vivo.
High Affinity Hox Binding Sites Decreased the Specificity of Enhancer Function Replacement of native sites with high affinity sites caused ectopic expression mostly outside of the domains of Ubx and abdA expression ( Figure S5 ), suggesting that these high affinity sites bound transcription factors other than Ubx and AbdA. Indeed, in embryos deficient for Ubx, the E3N enhancers with high affinity binding sites showed the expected reduction of expression in A1 (where Ubx is the only Hox gene active), but they also continued to drive ectopic expression in anterior segments ( Figures 5A-5D ).
Sex comb reduced (Scr) was an attractive candidate for driving some of the ectopic anterior expression of svb enhancers carrying high-affinity sites. Scr is expressed in anterior segments (Kuroiwa et al., 1985) and SELEX-seq data indicated that ScrExd can bind to high-affinity Ubx/Exd binding sites (Slattery et al., 2011) . When assayed on the E3N svb enhancer, Scr-Exd showed little or no in vitro binding to the native E3N sites, but it bound to the high affinity sites even more strongly than UbxExd bound to the native sites ( Figure 5E ). In vivo, uniform expression of Scr produced no obvious changes in the expression of wild-type E3N ( Figures 5F and 5G ), but drove ectopic expression of E3N variants that carried one high-affinity site ( Figures  5H-5K) . Thus, replacing low affinity Ubx/AbdA-Exd sites with high-affinity sites enabled the E3N enhancer to respond to Scr. In addition to Scr, it is likely that other homeodomain transcription factors bind and activate the E3N enhancers carrying high-affinity sites to generate their broad domains of ectopic expression.
Together, our results indicate that the native low affinity Ubx/AbdA-Exd binding sites in the E3N enhancer confer specificity for Ubx-Exd and AbdA-Exd over other Hox proteins, such as Scr, and probably over additional homeodomain factors.
Clusters of HOX Binding Sites Confer Robustness to Genetic and Environmental Variability
As discussed earlier, some of the Ubx/AbdA-Exd binding sites in the E3N and 7H enhancers can be mutated with minimal effects on reporter gene expression (Figures 2 and S4) . It is not clear, therefore, why these enhancers contain multiple Hox binding sites. We wondered if the multiple, apparently redundant, UbxExd binding sites within individual svb enhancers contribute to transcriptional robustness, in the same way that multiple enhancers of svb confer robustness in the face of environmental and genetic variation (Frankel et al., 2010) . 
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Figure 4. Conversion of Low Affinity Ubx-Exd Binding Sites to Higher Affinity Sites Results in Ectopic Expression
To test this hypothesis, first we examined the effects of altered levels of Ubx on the expression of E3N enhancers. The wild-type E3N enhancer drove normal expression in embryos heterozygous for an Ubx null mutation ( Figures 6A, 6B, 6M, and 6N) . In contrast, all E3N enhancers that contained single mutations in the Ubx-Exd binding sites drove dramatically lower levels of expression in Ubx heterozygotes, compared to wild-type embryos ( Figures 6C-6T ). Similar effects were observed for most combinations of the mutations ( Figures 6I, 6J, 6U , and 6V). These Next, we assayed the effects of environmental variation on enhancer activity by exploiting the fact that svb enhancers driving a svb cDNA in svb null embryos provide a sensitive and quantitative readout of enhancer function (Frankel et al., 2010 (Frankel et al., , 2011 . We reared embryos at 17 C and 32 C, temperature extremes that are still compatible with normal development (Powsner, 1935) . In embryos carrying the wild-type E3N::svb rescue construct, trichome numbers were relatively invariant to temperature extremes ( Figure 6C 0 ). In contrast, enhancers containing a single mutated Ubx/Exd binding site showed reduced rescue of trichomes at extreme temperatures ( Figure 6C 0 ). Furthermore, the simultaneous mutation of site 1 and 2 abrogated trichome rescue at extreme temperatures, while other double or triple combinations led to no rescue ( Figure 6C 0 ). These results indicate that multiple Ubx-Exd binding sites are required for normal enhancer function and to cope with variable genetic backgrounds and environments, similar to conditions faced by flies in the wild.
Ubx Binds a Cluster of Low Affinity Binding Sites in the Orthologous E3N Enhancer from a Distantly Related Species
We wondered whether the enhancer architecture discovered for E3N and 7H, with homotypic clusters of low affinity Hox-Exd sites, is an evolutionarily conserved feature of svb enhancers.
Because the large-scale cis-regulatory landscape of svb has been well conserved in Drosophila virilis (Frankel et al., 2012) , we examined this question by focusing on the E3N region of D. virilis.
Drosophila melanogaster and D. virilis last shared a common ancestor 40 mya and the E3N region displays little sequence conservation between these species ( Figure 7A ). We thus employed EMSAs to identify, in an unbiased manner, all of the Ubx-Exd binding sites putatively present in the D. virilis E3N Tables S1 and S2. orthologous region (VE3N). We found that four fragments-VE3N1, VE3N2, VE3N5, and VE3N9-bound Ubx-Exd in vitro ( Figures 7B-7D ). Comprehensive mutagenesis of these fragments revealed five Ubx-Exd binding sites ( Figures 7B, 7C , and S7). One of these sites is evolutionarily conserved and four sites display no sequence conservation to D. melanogaster and only weak conservation to closely related species (Figure 7A) . As observed for D. melanogaster, none of the Ubx-Exd binding sites of VE3N were detected by SELEX-seq, indicating that they are low affinity sites. We next tested whether these Ubx-Exd sites function in vivo by generating transgenic D. melanogaster lines that contained either the wild-type or mutated D. virilis VE3N enhancers. The wild-type VE3N enhancer drove lower levels of expression than did its D. melanogaster E3N counterpart ( Figures 7E-7H) , a result observed often in tests of orthologous enhancers (Crocker et al., 2008; Ludwig et al., 1998) . Mutation of the conserved site present in VE3N resulted in the loss of reporter expression (Figures 7I and 7J) . To test if only this site was required for VE3N expression, we mutated the four nonconserved sites, leaving the conserved site intact. This reporter also displayed very little VE3N activity (Figures 7K and 7L) . Therefore, multiple Ubx-Exd binding sites, at least some of which are poorly conserved, contribute to the proper regulation of the D. virilis VE3N enhancer.
Taken together, these results indicate that clustering of low affinity Ubx-Exd sites is an evolutionarily conserved strategy used by svb enhancers, although many of the individual binding sites are not conserved across species.
DISCUSSION
We have demonstrated that the Hox protein Ubx regulates separate enhancers of the svb gene by binding, with its cofactors Exd and Hth, to clusters of low affinity binding sites. Combining in vitro and in vivo assays, we provided experimental demonstration of an affinity-specificity tradeoff for Hox proteins, such that enhancers that integrate Hox inputs to drive regionalized expression are unlikely to utilize high affinity Hox binding sites. Forced to utilize low affinity sites, enhancers have evolved to contain multiple binding sites to ensure regulatory robustness to genetic and environmental variations. Most individual Ubx-Exd sites have evolved rapidly, but evolution has conserved overall enhancer architecture, with clusters of low affinity sites.
Homotypic clusters of transcription factor binding sites are pervasive in animal genomes (Arnone and Davidson, 1997; Gotea et al., 2010; Lifanov et al., 2003; Ochoa-Espinosa et al., 2005; Papatsenko et al., 2002; Stanojevic et al., 1991) and several models have been proposed to explain their existence (Doniger et al., 2005; Giorgetti et al., 2010; He et al., 2012; Segal et al., 2008) . Our results provide experimental evidence that homotypic clusters of Hox binding sites can confer robustness to enhancers. This may reflect a more widespread phenomenon. Although many enhancers contain homotypic clusters with low affinity sites, previous studies have rarely detected changes in expression by deleting individual binding sites (Doniger and Fay, 2007; Estella et al., 2008; Giorgianni and Mann, 2011; Hersh and Carroll, 2005; Saramä ki et al., 2006; Stanojevic et al., 1991) . However, these mutated enhancers have not been tested in variable environments. It is possible that many of these clustered sites confer regulatory robustness.
It is useful to compare our results with previous studies that have demonstrated specific regulatory functions for homotypic clusters. For example, clustered binding sites in an enhancer of the Drosophila hunchback gene mediate cooperative DNA binding by Bicoid, which provides threshold-dependent enhancer activity Lebrecht et al., 2005; Struhl et al., 1989) . In other cases, clusters of homotypic binding sites act in a noncooperative manner to allow enhancers to respond in a graded fashion (Giorgetti et al., 2010) , for example to determine expression levels in response to transcription factor concentrations Gaudet and Mango, 2002; Rowan et al., 2010) . It is worth noting that in these cases, where homotypic clusters mediate specific linear or nonlinear outputs, enhancers are bound by transcription factors that belong to small paralogous families: e.g., two paralogs for Msn2 (Hasan et al., 2002) ; three for p53 (Belyi et al., 2010) ; two for Dorsal (Silverman and Maniatis, 2001) ; and five for NFkB (Silverman and Maniatis, 2001 ). In contrast, there are 84 homeodomain-containing proteins encoded in the Drosophila genome, many with overlapping specificities (Berger et al., 2008; Noyes et al., 2008) . Therefore, in previously described examples of homotypic clusters, binding affinity may not be a strong constraint on specificity.
For the Hox regulated svb enhancers, low affinity Ubx/AbdAExd binding sites enable specificity, while the clustering of low affinity sites confers phenotypic robustness. This is a fundamentally different constraint on clustered binding sites than observed in all previous examples. The affinity-specificity tradeoff, initially supported by our computational analysis of in vitro data, was confirmed in vivo by progressively increasing the affinity of the Ubx-Exd binding sites. While replacement of low affinity sites with higher affinity sites always quantitatively altered enhancer activity, either positively or negatively, most higher affinity sites generated strong ectopic expression. As we show, this ectopic expression is driven, at least in part, by gaining the binding of additional Hox proteins, which are normally not involved in the regulation of these enhancers. Other studies have performed replacement of low affinity sites with higher affinity sites and, in some cases, they have also observed ectopic expression (Busser et al., 2012; Gaudet and Mango, 2002; Jiang and Levine, 1993; Peterson et al., 2012; Ramos and Barolo, 2013; Scardigli et al., 2003; Stewart-Ornstein et al., 2013; Struhl et al., 1989) . These altered patterns of expression may reflect increased sensitivity of enhancers to the same transcription factor that binds to the wild-type enhancer (Jiang and Levine, 1993) . We observed a similar effect for Ubx and AbdA-dependent upregulation of svb enhancers in the cells in which they are normally expressed. In addition, however, we found that sites with higher affinity resulted in a reduced specificity, due to the binding of additional homeodomain proteins, such as Scr, to svb enhancers. Our computational analyses suggest that this affinity-specificity tradeoff is a fundamental property of Hox proteins and would therefore influence the architecture of enhancers that must generate specific outputs in response to Hox factors. We suggest that transcription factors that belong to other large paralog groups may exhibit a similar affinity-specificity tradeoff and that enhancers regulated by these factors may also exploit clusters of low affinity sites.
Our results help to explain previous difficulties with bioinformatic prediction of functional Hox binding sites, because low affinity sites are difficult to detect reliably. Indeed, the low affinity sites that implement Hox regulation within svb enhancers share little similarity with canonical Hox or Hox-Exd binding sites. Consequently, a very large number of seemingly disparate DNA sequences can confer low affinity binding for Hox proteins. If Hox-Exd sites are often clustered in the genome, then signals from genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) will reflect binding to the entire cluster (as we observed) and the signals associated with individual low affinity sites may be difficult to discern from noise. Identification of important low affinity sites will require a change in computational approaches to analyzing genome-wide data. Currently, it is de rigueur to apply an arbitrary threshold to genome-wide data and then to analyze only signals above this threshold. This approach is likely to bias detection toward high affinity sites, whose functions may be distinct from those of clusters of low affinity sites.
Our findings provide insight into how different Hox proteins regulate specific target genes to generate phenotypic diversity across the anterior-posterior axis. One unanswered question is how the many low affinity DNA sequences, which appear to share little in common, are bound by the same Hox-Exd complex with apparently similar affinity. It is possible that variations in DNA shape (deviations from the structure of canonical B-DNA) influence Hox-Exd binding to low affinity sites (Dror et al., 2014; Joshi et al., 2007; Rohs et al., 2009) . It remains unclear if very different sequences can adopt similar shapes, or whether instead the Hox-Exd complex can recognize a range of shapes. Resolution of this question will require structural studies of HoxExd complexes bound to a range of low affinity DNA sequences and quantitative analysis of their binding dynamics in vivo.
EXPERIMENTAL PROCEDURES
Fly Strains and Transgenic Constructs DNA fragments were cloned into the reporter constructs placZattB and pHSPattB GFP and the pRSQsvb rescue construct (Frankel et al., 2011 ) (see Table S1 ). Mutations were introduced using site-directed mutagenesis (Genescript). Plasmids were integrated into the attP2 landing site by Rainbow Transgenic Flies. Additional strains used were: svb R9 /FM7c twi::GFP (Delon et al., 2003) ; HS::Ubx-1; Ubx 1 ; hth P2 (Noro et al., 2006) ; and Ubx 1 abdA-D24 AbdB D18 (Bloomington stock 1108).
Embryo Staining and Cuticles
Stage 15/16 embryos were collected, fixed, and stained using standard protocols with mouse anti-bGal (1:1,000, Promega) and anti-mouse AlexaFluor (1:500, Invitrogen) antibodies. Cuticles were prepared following standard protocols, imaged with phase-contrast microscopy, and ventral trichomes in larval A2 segments were counted.
Image Analysis
Embryos carrying reporter constructs were imaged on a Leica SPE Confocal Microscope. Sum projections of confocal stacks were assembled, images were scaled, background was subtracted using a 50-pixel rolling-ball radius and plot profiles of fluorescence intensity were analyzed using ImageJ software (http://rsb.info.nih.gov/ij). Data from the plot profiles were analyzed further in MATLAB (http://www.mathworks.com) (Crocker and Stern, 2013) .
In Vitro Affinity-Specificity Tradeoff Calculations Average relative affinities of 12mers from SELEX-seq data (Slattery et al., 2011) were calculated for four pairs of Hox-Exd complexes that share similar binding preferences: (1) Labial and Pb, (2) Dfd and Scr, (3) Antp and AbdB, and (4) Ubx and AbdA. Specificity groups (colored bars in Figure 3) were defined as having an average relative affinity R0.05 for bound complexes and <0.03 for unbound complexes. The proportion and total number of sequences in each specificity group were calculated for ten bins based on their Ubx/AbdA-Exd relative affinities.
DNA Alignments
Multiple sequence alignments were performed using Geneious (http://www. geneious.com) with MUSCLE alignment algorithms (anchor optimized).
Protein Purification and EMSAs
Ubx (isoform IVa), abdA, Hth HM -Exd, and Hth FL -Exd constructs, protein purification, and EMSA conditions were described previously (Lelli et al., 2011) . Further experimental details are provided in Table S2 .
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